LFVN logo

LFVN LifeVantage Corporation

NASDAQ Capital Market · Packaged Foods · Consumer Defensive

$6.07
-0.17 (-2.72%)

LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions,…

Market Cap: $76.58Mwww.lifevantage.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
40
2 mentions
—
60d
55
8 mentions
—
90d
55
8 mentions
—
news: 8

Analyst Ratings

3 analysts
Holdconsensus
Strong Buy 0Buy 1Hold 2Sell 0Strong Sell 0
Avg price target$6-1.2%
Low $6Median $6High $6
Current Consensus

Revenue

$42.38M-22.80%
$42.38M$50.84M$59.30M$67.76M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$0.81
$0.79–$0.84
1 analysts
FY2026
$0.56-31% YoY
$0.55–$0.58
1 analysts
FY2027
$0.32-42% YoY
$0.31–$0.33
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Terrence Moorehead
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
216
Beta
0.76
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
2.89
www.lifevantage.com